Federated Hermes
ALXO icon

Federated Hermes’s ALX Oncology ALXO Stock Holding History

Federated Hermes’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,374
Closed -$4.34K – 2073
2025
Q3 		$4.34K Sell
2,374
-4,167
-64% -$3.61K ﹤0.01% 1956
2025
Q2 		$2.71K Hold
6,541
– – ﹤0.01% 1939
2025
Q1 		$4.08K Buy
6,541
+2,058
+46% +$2.47K ﹤0.01% 1899
2024
Q4 		$7.49K Buy
+4,483
New +$6.89K ﹤0.01% 1864
2024
Q3 		– Sell
-2,329
Closed -$14K – 2059
2024
Q2 		$14K Sell
2,329
-199,033
-99% -$2.45M ﹤0.01% 1753
2024
Q1 		$2.25M Buy
201,362
+4,826
+2% +$67.8K 0.01% 910
2023
Q4 		$2.93M Sell
196,536
-54,824
-22% -$520K 0.01% 851
2023
Q3 		$1.21M Sell
251,360
-3,610
-1% -$19.6K ﹤0.01% 1052
2023
Q2 		$1.91M Sell
254,970
-255,696
-50% -$1.67M ﹤0.01% 963
2023
Q1 		$2.31M Buy
510,666
+46,637
+10% +$353K 0.01% 912
2022
Q4 		$5.23M Sell
464,029
-685
-0.1% -$7.69K 0.01% 679
2022
Q3 		$4.45M Buy
464,714
+7,961
+2% +$92.8K 0.01% 696
2022
Q2 		$3.69M Buy
456,753
+402,646
+744% +$4.38M 0.01% 764
2022
Q1 		$914K Buy
+54,107
New +$924K ﹤0.01% 1277
2020
Q4 		– Sell
-5,000
Closed -$188K – 2234
2020
Q3 		$188K Buy
+5,000
New +$197K ﹤0.01% 1661

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Federated Hermes's ALXO Position: Q4 2025 in Review

Federated Hermes sold out of ALX Oncology (ALXO) in Q4 2025, closing a stake of 2,374 shares — an estimated $4.34K sold.

Federated Hermes first reported a position in ALXO in Q3 2020 and held it in 15 quarters. The position peaked at $5.23M in Q4 2022. 57 funds tracked by Wall St. Rank hold ALXO as of Q4 2025.

  • Federated Hermes reported no remaining ALX Oncology position as of Q4 2025 after selling out during the quarter.
  • Federated Hermes sold 2,374 ALX Oncology shares in Q4 2025, an estimated $4.34K.
  • Federated Hermes first reported a position in ALX Oncology in Q3 2020 and held it in 15 quarters.
  • Federated Hermes's ALX Oncology position peaked at $5.23M in Q4 2022.
  • 57 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2025.

Based on Federated Hermes's 13F filing for Q4 2025, filed 12 Feb 2026.